Current status and prospects of immunotherapy in esophageal cancer / 国际肿瘤学杂志

ABSTRACT

The treatment of esophageal cancer is difficult in clinic.Recently,the development of immune checkpoint inhibitors has brought the immunotherapies to a new age.In predicting the curative effect of biomarkers,programmed cell death-ligand 1,tumor mutation burden and microsatellite instability could promisingly predict the effect of the immune checkpoint inhibitors.Various immune checkpoint inhibitors are emerging and the combination of immunotherapy have shown a great applied potential in a series of clinical trials of esophageal cancer.